Foreword.
- Published in:
- touchREVIEWS in Oncology & Haematology, 2024, v. 20, n. 2, p. 1
- By:
- Publication type:
- Article
Works matching IS 27525481 AND DT 2024 AND VI 20 AND IP 2
Results: 8
1
2
Advancements in Immune Checkpoint Inhibitors for Oesophageal Squamous Cell Carcinoma: Current Status and Future Perspectives.
- Published in:
- touchREVIEWS in Oncology & Haematology, 2024, v. 20, n. 2, p. 34, doi. 10.17925/OHR.2024.20.2.5
- By:
- Publication type:
- Article
3
Advances in Targeting KRAS G12C in Gastrointestinal Malignancies: Focus on KRAS G12C Inhibitors.
- Published in:
- touchREVIEWS in Oncology & Haematology, 2024, v. 20, n. 2, p. 25, doi. 10.17925/OHR.2024.20.2.7
- By:
- Publication type:
- Article
4
Redefining Treatment Paradigms in Metastatic Castration-resistant Prostate Cancer: A Comprehensive Analysis of Cabozantinib and Atezolizumab Based on the CONTACT-02 Study Results.
- Published in:
- touchREVIEWS in Oncology & Haematology, 2024, v. 20, n. 2, p. 45, doi. 10.17925/OHR.2024.20.2.3
- By:
- Publication type:
- Article
5
Gauging the Online Public Interest in Breast Cancer in Pakistan.
- Published in:
- touchREVIEWS in Oncology & Haematology, 2024, v. 20, n. 2, p. 2, doi. 10.17925/OHR.2024.20.2.1
- By:
- Publication type:
- Article
6
Mesothelioma and Immunotherapies.
- Published in:
- touchREVIEWS in Oncology & Haematology, 2024, v. 20, n. 2, p. 39, doi. 10.17925/OHR.2024.20.2.4
- By:
- Publication type:
- Article
7
Trifluridine/Tipiracil and Bevacizumab in Adults with Refractory Metastatic Colorectal Cancer.
- Published in:
- touchREVIEWS in Oncology & Haematology, 2024, v. 20, n. 2, p. 19, doi. 10.17925/OHR.2024.20.2.6
- By:
- Publication type:
- Article
8
A Comprehensive Review of the Growing Landscape of Endocrine and Biologic Treatments for Hormone Receptor-positive Breast Cancer.
- Published in:
- touchREVIEWS in Oncology & Haematology, 2024, v. 20, n. 2, p. 5, doi. 10.17925/OHR.2024.20.2.2
- By:
- Publication type:
- Article